|
인쇄하기
취소
|
KPA opposes further expansion of exceptional SDP function
Published: 2003-09-02 06:56:00
Updated: 2003-09-02 06:56:00
The Korea Pharmaceutical Association said recently that it opposes the proposed Pharmaceutical Affairs Law's revision plan to exceptionally expand the current SDP function to patients with national merits and those who have suffered from sequelae of orange agents, noting that the plan will impair the principle and purport of the current system and deepen severe dispute in the related community....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.